Cabozantinib Cutaneous Toxicity—Comprehensive Review
Background: In the context of modern cancer therapy, the management of adverse effects of systemic therapies can lead to the avoidance of underdosing and withdrawal and increases in the quality of the therapeutic act and the quality of life. This review offers an overview of the skin-related toxicit...
Saved in:
Main Authors: | Cristina Violeta Tutunaru, Dragos Ovidiu Alexandru, Sanda Amelia Dracea, Loredana Ungureanu, Liliana Gabriela Popa, Cristina Beiu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/15/1/72 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Severe cutaneous drug toxicity following disitamab vedotin treatment for metastatic gastric cancer: a case report
by: Zhao Luping, et al.
Published: (2025-01-01) -
Pharmacovigilance imbalance analysis of VEGFR-TKI-related taste and smell disorders
by: Zhong-hua Fu, et al.
Published: (2025-01-01) -
Palbociclib-induced Toxic Epidermal Necrolysis: A Case Report with Review of All Cases Secondary to Cyclin-dependent Kinase 4/6 Inhibitors
by: Aurore Devoldere, et al.
Published: (2025-01-01) -
A Clinico-Epidemiological Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Centre of Eastern India
by: Sujata Sinha, et al.
Published: (2024-01-01) -
Association of Cutaneous Immune-related Adverse Events with Overall Survival and Progression-free Survival in Oncology Patients Receiving Immune Checkpoint Inhibitors: A Prospective Study of 189 Patients in a Spanish Tertiary Care Hospital
by: Gloria Juan-Carpena, et al.
Published: (2025-01-01)